March 18, 2020

For several weeks, the employer community has petitioned the IRS to issue new guidance on the use of high-deductible heath plans (HDHPs) and health savings accounts (HSAs) to pay for Coronavirus (COVID-19) testing and treatment.

On March 11, the IRS set out new guidance in Notice 2020-15:

“To facilitate the nation’s response to the 2019 Novel Coronavirus (COVID-19), this notice provides that [...] a health plan that otherwise satisfies the requirements to be a high deductible health plan (HDHP) [...] will not fail to be an HDHP [...] merely because the health plan provides health benefits associated with testing for and treatment of COVID-19 without a deductible, or with a deductible below the minimum deductible (self only or family) for an HDHP.”

Above is an excerpt from Notice 2020-15. Read the full notice here.